Esther I Verhoef
Overview
Explore the profile of Esther I Verhoef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rijstenberg L, Harikumar H, Verhoef E, van den Bosch T, Choiniere R, van Royen M, et al.
Histopathology
. 2025 Jan;
PMID: 39888049
Aims: Intraductal carcinoma (IDC) is an independent pathological parameter for adverse prostate cancer (PCa) outcome. Although most IDC are believed to originate from retrograde spread of established PCa, rare IDC...
2.
Van Hemelryk A, Tomljanovic I, de Ridder C, Stuurman D, Teubel W, Erkens-Schulze S, et al.
Cells
. 2022 Nov;
11(22).
PMID: 36429059
Castration-resistant prostate cancer (CRPC) remains an incurable and lethal malignancy. The development of new CRPC treatment strategies is strongly impeded by the scarcity of representative, scalable and transferable preclinical models...
3.
Hansum T, Hollemans E, Verhoef E, Bangma C, Rietbergen J, Osanto S, et al.
Mod Pathol
. 2021 Jun;
34(11):2064-2070.
PMID: 34175896
Individual growth patterns and cribriform architecture are increasingly considered in risk stratification and clinical decision-making in men with prostate cancer. Our objective was to establish the prognostic value of individual...
4.
Boamfa M, Asselman M, Vulders R, Verhoef E, van Royen M, van der Zaag P
J Biomed Opt
. 2020 Nov;
25(11).
PMID: 33215476
Significance: Currently, tissue biopsies are sectioned into 3- to 5-μm-thick slices that are used for conventional pathology analysis. Previous work by confocal microscopy and light-sheet microscopy has shown that analyzing...
5.
Hollemans E, Verhoef E, Bangma C, Rietbergen J, Osanto S, Pelger R, et al.
Mod Pathol
. 2020 Jul;
34(1):184-193.
PMID: 32686748
The Gleason score is an important parameter for clinical outcome in prostate cancer patients. Gleason score 8 is a heterogeneous disease including Gleason score 3 + 5, 4 + 4,...
6.
van Leenders G, Verhoef E, Hollemans E
Histopathology
. 2020 Jul;
77(6):850-861.
PMID: 32683729
The Gleason grading system is one of the most important factors in clinical decision-making for prostate cancer patients, and is entirely based on the classification of tumour growth patterns. In...
7.
Hollemans E, Verhoef E, Bangma C, Rietbergen J, Osanto S, Pelger R, et al.
Mod Pathol
. 2020 Feb;
33(8):1618-1625.
PMID: 32080350
Glomeruloid architecture is the least common Gleason 4 growth pattern in prostate adenocarcinoma. Its clinicopathological features and relation with cribriform architecture, which has been recognized as an adverse feature, remains...
8.
Hollemans E, Verhoef E, Bangma C, Rietbergen J, Roobol M, Helleman J, et al.
Histopathology
. 2020 Jan;
76(5):755-762.
PMID: 31944367
Aims: Invasive cribriform and intraductal carcinoma are associated with aggressive disease in Grade Group 2 (GG2) prostate cancer patients. However, the characteristics and clinical outcome of patients with GG2 prostate...
9.
Verhoef E, Kweldam C, Kummerlin I, Nieboer D, Bangma C, Incrocci L, et al.
Arch Pathol Lab Med
. 2020 Jan;
PMID: 31904279
Context.—: Prostate biopsy reports require an indication of prostate cancer volume. No consensus exists on the methodology of tumor volume reporting. Objective.—: To compare the prognostic value of different biopsy...
10.
Hollemans E, Verhoef E, Bangma C, Rietbergen J, Helleman J, Roobol M, et al.
Am J Surg Pathol
. 2019 Oct;
44(2):191-197.
PMID: 31592799
Postoperative biochemical recurrence occurs in up to 40% of prostate carcinoma patients treated with radical prostatectomy. Primary tumor grade and cribriform architecture are important parameters for clinical outcome; however, their...